Metabolic Disease Contract Research Market is Growing at 17% A Year

12/giu/2018 13:41:45 The Business Research Company Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.


The largest segment of the $ 44 billion contract research market is for clinical studies to develop cancer therapies, but the smaller metabolic disease segment is growing much faster  .

The global market for clinical trials is expected to grow at 12% year on year to 2021. That is accelerating from its rate of 10% up to 2017 which raised its value to $ 44.4 billion.

Contract Research Organizations (CROs) are service providers offering clinical trials, including initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory functions, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Many companies already outsource their R & D activities to increase their outsourcing of drug development processes to CROs in the future.

North America is the largest region for the production of CRO services, at $ 18.8 billion, while CRO consumption in North America is worth $ 20.8 billion or about 47% of the global total. Drug development in the region, especially in the USA. The production / consumption difference is lower than the cost of offshore locations for some CRO activities by US pharmaceutical companies, although the majority of US outsourced activity remains within the country.

Declining growth in the pharmaceutical market, although not in an obvious way. Recently, the double-digit growth rates of pharmaceutical and biotechnology have been shrinking to single digits. Pharmaceuticals and biotechnology companies have been involved in outsourcing. Several companies have already adopted this strategy and outsourced their processes to specialist service providers such as CROs.

IQVIA is the largest player in the global CRO market with 12.4% share, followed by the Laboratory of America Holdings, ICON Plc, PAREXEL, and PPD.

Where to learn more
Read the 
Contract Research Organizations Market Report  from  The Business Research Company  for information on the following:
Markets Covered
i) CRO's By Type of Services - drug discovery, preclinical studies, phase 1, phase 2, phase 3, phase 4 and others; 
ii) CRO's By Therapeutic Area - oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others.
Contract Research Organizations Mentioned : IQVIA, Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD
Countries : India, China, Japan, Australia, UK, Germany, France, Italy, Spain, Russia, USA, Brazil

Regions : North America, South America, Western Europe, Eastern Europe, Africa, Middle East, Asia Pacific

Time Series : Five years historic and forecast.

Data : Ratios of market size and growth to related markets, population, GDP, Contract Research Organizations Indicators Comparison.

Data Segmentations : market share of competitors, market segments.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company, which excels into the company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293 Email:




blog comments powered by Disqus è un servizio offerto da Factotum Srl